ArticlePediatric cardiology2026
Left Atrial Function in Children with Cancer Prior to Start of Chemotherapy: A Speckle Echocardiography Analysis.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left ventricle (LV) systolic dysfunction, which has been observed in pediatric patients with cancer even prior to chemotherapy, is associated with adverse cardiac events on short-term follow-up. Left atrium (LA) function is pivotal in LV filling and output. Our aim was to evaluate LA function and dimensions before starting chemotherapy in children with cancer, compared to controls. This retrospective cross-sectional study assessed echocardiographic LA function in asymptomatic children with cancer before starting chemotherapy and normal controls. LA function was assessed during the reservoir phase (LASr) denoting LA filling, the passive emptying conduit phase (LAScd) and the active atrial contraction booster phase (LASbo) of the LA strain curve. LV diastolic functional parameters, mitral valve early filling maximum velocity (E), atrial filling maximum velocity (A) and tissue Doppler imaging (E' and A') were concurrently measured. The pre-chemotherapy (n = 79) and control (n = 80) groups had comparable gender and age at echocardiogram and similar LASr (39.0% ± 9.2% vs. 39.0% ± 9.1%, p = 0.99). However, LAScd was significantly lower (23.1% ± 11.3% vs. 28.6% ± 8.6%, p < 0.05) and was compensated by increased LASbo function (15.9% ± 11.2% vs. 10.4% ± 7.5%, p < 0.05) in the pre-chemotherapy group, compared to controls. Our data demonstrating abnormalities in LA functional strain parameters in children with cancer, prior to chemotherapy, are novel and perplexing. These LA strain abnormalities may be associated with cancer related systemic effects or inflammatory cytokine release, though the exact mechanisms require further investigation.
Indexed as
Identifiers
42377446What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.